NL300195I2 - Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC. - Google Patents

Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC.

Info

Publication number
NL300195I2
NL300195I2 NL300195C NL300195C NL300195I2 NL 300195 I2 NL300195 I2 NL 300195I2 NL 300195 C NL300195 C NL 300195C NL 300195 C NL300195 C NL 300195C NL 300195 I2 NL300195 I2 NL 300195I2
Authority
NL
Netherlands
Prior art keywords
ftc
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Application number
NL300195C
Other languages
English (en)
Other versions
NL300195I1 (nl
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300195(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL300195I1 publication Critical patent/NL300195I1/nl
Publication of NL300195I2 publication Critical patent/NL300195I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NL300195C 1995-03-30 2005-05-09 Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC. NL300195I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (2)

Publication Number Publication Date
NL300195I1 NL300195I1 (nl) 2005-08-01
NL300195I2 true NL300195I2 (nl) 2005-11-01

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300195C NL300195I2 (nl) 1995-03-30 2005-05-09 Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC.

Country Status (36)

Country Link
US (1) US6417191B1 (nl)
EP (1) EP0817637B1 (nl)
JP (1) JP2954357B2 (nl)
KR (1) KR100542536B1 (nl)
CN (1) CN1103593C (nl)
AP (1) AP652A (nl)
AT (1) ATE220551T1 (nl)
AU (1) AU715213B2 (nl)
BR (3) BR9607851B1 (nl)
CA (1) CA2216634C (nl)
CZ (1) CZ295940B6 (nl)
DE (3) DE122005000029I1 (nl)
DK (1) DK0817637T3 (nl)
EA (1) EA000626B3 (nl)
EE (1) EE04047B1 (nl)
ES (1) ES2179193T3 (nl)
FR (1) FR05C0022I2 (nl)
GE (1) GEP20022647B (nl)
HK (1) HK1009401A1 (nl)
HU (1) HU224010B1 (nl)
IL (1) IL117727A (nl)
LU (1) LU91171I2 (nl)
MX (1) MX9707316A (nl)
MY (1) MY115461A (nl)
NL (1) NL300195I2 (nl)
NO (2) NO313787B1 (nl)
NZ (1) NZ306419A (nl)
OA (1) OA10616A (nl)
PL (1) PL187085B1 (nl)
PT (1) PT817637E (nl)
RO (1) RO117995B1 (nl)
SI (1) SI0817637T1 (nl)
SK (1) SK283825B6 (nl)
TR (1) TR199701074T1 (nl)
UA (1) UA60293C2 (nl)
WO (1) WO1996030025A1 (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ429498A3 (cs) * 1996-06-25 1999-06-16 Glaxo Group Limited Kombinace obsahující VX478, zidovudin, FTC a/nebo 3TC pro léčbu infekce HIV
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
WO1998052570A1 (en) * 1997-05-17 1998-11-26 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
CA2374198A1 (en) * 1998-05-29 1999-12-02 Maki Arai Combination therapy for treatment of fiv infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
CA2512319A1 (en) * 2003-01-14 2004-08-05 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AU2004224191A1 (en) 2003-03-24 2004-10-07 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
DE602004030369D1 (de) 2003-10-24 2011-01-13 Immunaid Pty Ltd Therapieverfahren
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
KR20080056220A (ko) 2005-10-19 2008-06-20 에프. 호프만-라 로슈 아게 페닐-아세트아마이드 ｎｎｒｔ 저해제
JP5415957B2 (ja) 2006-12-13 2014-02-12 エフ．ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としての２−（ピペリジン−４−イル）−４−フェノキシ−又はフェニルアミノ−ピリミジン誘導体
WO2008095263A1 (en) * 2007-02-09 2008-08-14 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
EP2982978A1 (en) 2009-05-27 2016-02-10 Immunaid Pty Ltd Methods of treating diseases
EP3351249A1 (en) 2010-01-27 2018-07-25 VIIV Healthcare Company Antiviral therapy
MX2016002560A (es) 2013-08-29 2016-10-26 Teva Pharma Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
AU2015245217A1 (en) 2014-04-08 2016-10-13 Teva Pharmaceutical Industries Ltd. Unit dosage form comprising Emtricitabine, Tenofovir, Darunavir and Ritonavir
CN117164657A (zh) 2014-08-12 2023-12-05 莫纳什大学 定向淋巴的前药
US11738087B2 (en) 2015-09-08 2023-08-29 Monash University Lymph directing prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
EP4306524A2 (en) * 2017-08-29 2024-01-17 PureTech LYT, Inc. Lymphatic system-directing lipid prodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
EP0513917B2 (en) * 1991-05-16 2001-03-07 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
DK0639971T3 (da) * 1992-05-13 2000-03-20 Wellcome Found Terapeutiske kombinationer
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
ATE230267T1 (de) 1996-06-25 2003-01-15 Glaxo Group Ltd Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
CZ429498A3 (cs) 1996-06-25 1999-06-16 Glaxo Group Limited Kombinace obsahující VX478, zidovudin, FTC a/nebo 3TC pro léčbu infekce HIV
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
AU715213B2 (en) 2000-01-20
EE04047B1 (et) 2003-06-16
NO974510L (no) 1997-09-29
AU5497296A (en) 1996-10-16
BR9607851A (pt) 1998-07-21
IL117727A0 (en) 1996-07-23
BR9607851B1 (pt) 2009-01-13
CN1185110A (zh) 1998-06-17
LU91171I9 (nl) 2018-12-28
IL117727A (en) 1999-11-30
CN1103593C (zh) 2003-03-26
BRPI9607851B8 (pt) 2019-11-05
DE122005000029I2 (de) 2006-04-27
CA2216634C (en) 2004-07-20
PL322532A1 (en) 1998-02-02
DE69622386T2 (de) 2003-02-13
FR05C0022I1 (nl) 2005-06-10
AP9701089A0 (en) 1997-10-31
GEP20022647B (en) 2002-03-25
BRPI9612992B1 (pt) 2020-08-04
CZ295940B6 (cs) 2005-12-14
EA000626B1 (ru) 1999-12-29
CA2216634A1 (en) 1996-10-03
LU91171I2 (fr) 2005-07-04
NO313787B1 (no) 2002-12-02
NO2005014I2 (no) 2008-02-11
EA199700203A1 (ru) 1998-02-26
US6417191B1 (en) 2002-07-09
EP0817637B1 (en) 2002-07-17
KR100542536B1 (ko) 2006-03-23
DE122005000029I1 (de) 2005-10-06
RO117995B1 (ro) 2002-12-30
SK129597A3 (en) 1998-07-08
EA000626B3 (ru) 2016-04-29
MX9707316A (es) 1997-11-29
DE69622386D1 (de) 2002-08-22
NO2005014I1 (no) 2005-06-06
SK283825B6 (sk) 2004-02-03
WO1996030025A1 (en) 1996-10-03
HK1009401A1 (en) 1999-09-10
JPH10511682A (ja) 1998-11-10
EP0817637A1 (en) 1998-01-14
FR05C0022I2 (nl) 2005-10-21
EE9700240A (et) 1998-04-15
HUP9801571A2 (hu) 1999-01-28
HUP9801571A3 (en) 2001-04-28
SI0817637T1 (en) 2002-10-31
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
UA60293C2 (uk) 2003-10-15
HU224010B1 (hu) 2005-04-28
NO974510D0 (no) 1997-09-29
AP652A (en) 1998-06-19
DK0817637T3 (da) 2002-11-11
PL187085B1 (pl) 2004-05-31
ES2179193T3 (es) 2003-01-16
KR19980703420A (ko) 1998-11-05
ATE220551T1 (de) 2002-08-15
CZ309097A3 (cs) 1998-05-13
JP2954357B2 (ja) 1999-09-27
OA10616A (en) 2001-03-15
MY115461A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
NL300195I1 (nl) Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC.
TR199600697A2 (tr) Tasit gövdesi yapisi.
BR9701946B1 (pt) composição condicionadora da pele.
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NL1011057A1 (nl) Gebruik van neonicotinoïden bij bestrijding van plagen.
NO986034D0 (no) Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
BR9701947B1 (pt) composição condicionadora da pele.
IT9022341A0 (it) Estratti da tessuti animali, utili in terapia e in diagnostica.
TR199601012A2 (tr) Sampuan terkibi.
DE59812250D1 (de) Gehstütze, stock oder dgl.
BR9401367A (pt) Composição contendo hidrolisado de cereal, composição de carne contendo imitador de gordura, e composição de carne fragmentada.
DE29721290U1 (de) Fleischmasse o.dgl.
AU3262697A (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
NL1000279C2 (nl) Met hitte behandelde polysacharidecrème.
NL1000591C2 (nl) Weefsel.
NO307542B1 (no) Kasseformet legeme, særlig postkasse, samt front til samme
DE29512877U1 (de) Briefhülle o.dgl.
BR7601412U (pt) Aparelho aplicável no tratamento de fluxo de graos em geral
ITRM950514A0 (it) Schiaccianoci imperio.
RU95117476A (ru) Природный дубитель кожи
ES1031649Y (es) Pinza para exprimir infusiones.
DE29514112U1 (de) Kegelspiel o.dgl.
ES1032202Y (es) Planeador cometa.
FI955877A0 (fi) I staellet foer en oljebytespropp monterbar vaermare foer smoerjolja